NCT06605469

Brief Summary

The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
37mo left

Started May 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
May 2024May 2029

Study Start

First participant enrolled

May 30, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

June 13, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2029

Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

5 years

First QC Date

June 13, 2024

Last Update Submit

February 12, 2025

Conditions

Keywords

ejaculatory dysfunctionpremature ejaculationdelayed ejaculationanorgasmiaanejaculationdysejaculationdysorgasmia

Outcome Measures

Primary Outcomes (1)

  • Primary Objective

    Report subjective efficacy of therapies used to treat ejaculatory dysfunction. Study participants will have the option of indicating if they had used any treatments to treat ejaculatory disorders. If so, they will then be asked to measure its efficacy at improving their symptoms using a 1-10 scale (10 being very effective).

    3 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult men (\>18) diagnosed with ejaculatory and/or orgasmic dysfunction who were recommended to begin any treatment for the condition For partners, inclusion is being a sexual partner of a man with ejaculatory and/or orgasmic dysfunction who is receiving treatment

You may qualify if:

  • Men being treated for either ejaculatory and/or orgasmic dysfunction

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Male Fertility and Peyronie's Clinic

Orem, Utah, 84057, United States

RECRUITING

MeSH Terms

Conditions

Ejaculatory DysfunctionPremature Ejaculation

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2024

First Posted

September 20, 2024

Study Start

May 30, 2024

Primary Completion (Estimated)

May 31, 2029

Study Completion (Estimated)

May 31, 2029

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Deidentified data will be made available to sites which have referred patients to the registry.

Locations